Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma - Related Studies

Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma (T-BiRD)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2011 by Weill Medical College of Cornell University.
Recruitment status was Recruiting

Study NCT00538733 Information provided by Weill Medical College of Cornell University

First Received on October 2, 2007. Last Updated on January 3, 2011 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Multiple Myeloma

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

thalomid
lenalidomide
clarithromycin
dexamethasone

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial